Company profile for Qualicaps

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Qualicaps® is a wholly-owned subsidiary of Mitsubishi Chemical Holdings Corporation (MCHC) through its Life Sciences Institute (LSII), which unites the Group’s healthcare business. MCHC is a Japanese chemical, industrial and healthcare company that aims to achieve a KAITEKI society, based on the philosophy “Good Chemistry for Tomorrow”. The Life Science Institute has the mission of offering the most advanced and high-qu...
Qualicaps® is a wholly-owned subsidiary of Mitsubishi Chemical Holdings Corporation (MCHC) through its Life Sciences Institute (LSII), which unites the Group’s healthcare business. MCHC is a Japanese chemical, industrial and healthcare company that aims to achieve a KAITEKI society, based on the philosophy “Good Chemistry for Tomorrow”. The Life Science Institute has the mission of offering the most advanced and high-quality solutions to contribute widely to people’s health, through all stakeholders, in an inspiring manner.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Avenida Monte Valdelatas, 4 28108 Alcobendas (Madrid)
Telephone
Telephone
+34 916 63 08 00
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.mg2.it/2024/04/08/qualicaps-distribution-agreement-sealing-machine-s125/

BIOSPACE
11 Apr 2024

https://www.pharmacompass.com/pdf/news/delzicol-mesalamine-allergan-qualicaps-v-teva-pharmaceuticals-usa-1494842920.pdf

PATENT LITIGATION
21 Apr 2017

http://www.pharmabiz.com/NewsDetails.aspx?aid=99036&sid=2

PHARMAIZB
02 Dec 2016
Qualicaps spent $43m to gain control of a $72bn market, reports
Qualicaps spent $43m to gain control of a $72bn market, reports

18 Feb 2016

// Gareth MacDonald+ IN PHARMATECHNOLOGY

http://www.in-pharmatechnologist.com/Drug-Delivery/Qualicaps-spent-43m-to-gain-control-of-a-72bn-market-reports

Gareth MacDonald+ IN PHARMATECHNOLOGY
18 Feb 2016

http://aux.cphi-online.com/qualicaps-acquires-genix-industria-farmaceutica-news039053.html

CPHI ONLINE
11 Feb 2016

Services

Upload your portfolio for free, ask us

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Excipients by Ingredients

Upload your portfolio for free, ask us

Excipients By applications

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty